A DIAMIDINE-RESISTANT TRYPANOSOMA-EQUIPERDUM CLONE CONTAINS A P2 PURINE TRANSPORTER WITH REDUCED SUBSTRATE AFFINITY

被引:79
作者
BARRETT, MP [1 ]
ZHANG, ZQ [1 ]
DENISE, H [1 ]
GIROUD, C [1 ]
BALTZ, T [1 ]
机构
[1] UNIV BORDEAUX 2, CNRS, URA 1637, F-33076 BORDEAUX, FRANCE
关键词
TRYPANOSOME DRUG RESISTANCE; BERENIL; PURINE TRANSPORTER;
D O I
10.1016/0166-6851(95)00120-P
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Following the demonstration that the transport of melaminophenyl arsenical drugs in Trypanosoma brucei is dependent upon an unusual adenosine nucleoside transporter (Carter and Fairlamb, Nature 361 (1993) 173-175) we have investigated adenosine transport in the related parasite Trypanosoma equiperdum (Botat1.1) and a cloned derivative resistant to the diamidine drug berenil (diminazene aceturate) with limited cross-resistance to the melaminophenyl arsenical cymelarsen. The parental strain possesses a bipartite adenosine transport system consisting of one component which is inhibited in a dose-dependent and saturable manner with increasing concentrations of inosine and a second component which is similarly inhibited by adenine. Uptake of adenosine on this second transporter is also inhibited in a dose-dependent fashion by berenil and cymelarsen. Both transporters have high affinity for adenosine (apparent K-m values of 0.60 and 0.70 mM and V-max values of 8.4 and 6.9 pmol (s (10(8) trypanosomes))(-1) at 25 degrees C, respectively). Thus T. equiperdum shares with T. brucei a system comprising two adenosine transporters named P1 and P2, respectively. The P1 transporter is similar in the sensitive and resistant T. equiperdum clones, whereas the P2 transporter has reduced transport capacity at physiological adenosine concentration and decreased affinity for adenosine in the drug-resistant clone.
引用
收藏
页码:223 / 229
页数:7
相关论文
共 18 条
[1]   RESISTANCE TO CLINICAL DRUGS IN AFRICAN TRYPANOSOMES [J].
BACCHI, CJ .
PARASITOLOGY TODAY, 1993, 9 (05) :190-193
[2]   CHARACTERIZATION OF PENTAMIDINE-RESISTANT TRYPANOSOMA-BRUCEI-BRUCEI [J].
BERGER, BJ ;
CARTER, NS ;
FAIRLAMB, AH .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1995, 69 (02) :289-298
[3]   ARSENICAL-RESISTANT TRYPANOSOMES LACK AN UNUSUAL ADENOSINE TRANSPORTER [J].
CARTER, NS ;
FAIRLAMB, AH .
NATURE, 1993, 361 (6408) :173-176
[4]   CELLULAR AND GENETIC-ASPECTS OF ANTIGENIC VARIATION IN TRYPANOSOMES [J].
CROSS, GAM .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :83-110
[5]   PENTAMIDINE TRANSPORT AND SENSITIVITY IN BRUCEI-GROUP TRYPANOSOMES [J].
DAMPER, D ;
PATTON, CL .
JOURNAL OF PROTOZOOLOGY, 1976, 23 (02) :349-356
[6]   NOVEL BIOCHEMICAL PATHWAYS IN PARASITIC PROTOZOA [J].
FAIRLAMB, AH .
PARASITOLOGY, 1989, 99 :S93-S112
[7]   CHARACTERIZATION OF MELARSEN-RESISTANT TRYPANOSOMA-BRUCEI-BRUCEI WITH RESPECT TO CROSS-RESISTANCE TO OTHER DRUGS AND TRYPANOTHIONE METABOLISM [J].
FAIRLAMB, AH ;
CARTER, NS ;
CUNNINGHAM, M ;
SMITH, K .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1992, 53 (1-2) :213-222
[8]   FLOW CYTOFLUOROMETRIC ANALYSIS OF DRUG ACCUMULATION BY MULTIDRUG-RESISTANT TRYPANOSOMA-BRUCEI BRUCEI AND TB-RHODESIENSE [J].
FROMMEL, TO ;
BALBER, AE .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1987, 26 (1-2) :183-191
[9]   UPTAKE OF PURINE-BASES AND NUCLEOSIDES IN AFRICAN TRYPANOSOMES [J].
JAMES, DM ;
BORN, GVR .
PARASITOLOGY, 1980, 81 (OCT) :383-393
[10]   PHARMACOLOGY OF EXISTING DRUGS FOR ANIMAL TRYPANOSOMIASIS [J].
KINABO, LDB .
ACTA TROPICA, 1993, 54 (3-4) :169-183